ArticleAmerican journal of nephrology2026

The Efficacy and Safety of Enarodustat for the Treatment of Anemia in Hemodialysis-Dependent Chronic Kidney Disease Patients: A Phase 3, Multicenter, Randomized, Active-Comparator (Recombinant Human Erythropoietin), Open-Label Study - The ENARODIAL Study.

Haishan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.